Search

Your search keyword '"Cox, A. (Angela)"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Cox, A. (Angela)" Remove constraint Author: "Cox, A. (Angela)"
68 results on '"Cox, A. (Angela)"'

Search Results

1. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

2. Rare germline copy number variants (CNVs) and breast cancer risk

3. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

4. Gene-environment interactions relevant to estrogen and risk of breast cancer:can gene-environment interactions be detected only among candidate SNPs from genome-wide association studies?

5. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

6. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

7. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

8. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

9. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

10. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

11. Genome-wide association study of germline variants and breast cancer-specific mortality

12. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

13. Shared heritability and functional enrichment across six solid cancers

14. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

15. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

16. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

17. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

18. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

19. Body mass index and breast cancer survival:a Mendelian randomization analysis

20. Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

21. Body mass index and breast cancer survival

22. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

23. Reproductive profiles and risk of breast cancer subtypes

24. PHIP:a novel candidate breast cancer susceptibility locus on 6q14.1

25. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

26. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

27. Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers

28. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

29. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

30. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

31. Genetic predisposition to ductal carcinoma in situ of the breast

32. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

33. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

34. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

35. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

36. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

37. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

38. Prediction of breast cancer risk based on profiling with common genetic variants

39. Identification of novel genetic markers of breast cancer survival

40. Common germline polymorphisms associated with breast cancer-specific survival

41. Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

42. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

43. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

44. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

45. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

46. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

47. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

48. MicroRNA related polymorphisms and breast cancer risk

49. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

50. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

Catalog

Books, media, physical & digital resources